Performance
Country
Manufacturers
Initiatives
in partnership with
Manufacturers
>
Generic Molecules
Help | Feedback | Favourites | User User1 Logout
Measure:
Volume
Value
Options




Top Generic Molecules
All Unprotected Products
Currency: GBP Manufacturer Prices Countries 6 ATC Category: All Sub-Segments All
Filter by Product Name Type:
Original
Unbranded
Branded

My Performance Market Performance Number of Suppliers
Assessment of product market share and sales relative to the market Market benchmark My suppliers vs total
My Market Share v My Avg Share
(Sales,%) Variance
(%pts) Sales/(Price) Opportunity
(£) My Market Share (Sales)
Total Sales
(£) Market Growth (Sales)
(excl. my sales)
No. of Suppliers in the Market No. of My Suppliers
(%) Change Change Trend Trend
ENOXAPARIN SODIUM
-0.4pts 401k 18.5 -0.4 Oct 201m -5.0% Oct
10 9
Germany
-0.3pts 152k 15.0 +0.6 Nov 88.0m -5.5% Nov
10 9
Italy
-1.0pts 191k 1.9 +0.3 Nov 51.6m -1.4% Oct
1 1
UK
+1.6pts (326k) 32.3 -2.3 Oct 34.9m -3.2% Oct
1 1
Austria
-0.7pts 55.3k 42.4 -0.4 Nov 14.1m -6.0% Oct
1 1
Belgium
+1.0pts (53.8k) 15.7 +2.3 Nov 8.0m -2.4% Oct
1 1
Portugal
+0.1pts (3.4k) 23.5 -2.8 Nov 4.8m +13.1% Nov
1 1
PREGABALIN
-6.5pts 10.7m 12.4 -6.4 Oct 178m -4.2% Oct
41 38
UK
-19.5pts 17.2m 11.3 -11.2 Oct 92.9m +1.0% Oct
5 2
Germany
+0.1pts (44.8k) 15.4 +0.5 Nov 59.1m +5.4% Nov
25 23
Italy
+0.2pts (33.0k) 3.1 +1.1 Nov 20.0m -22.0% Oct
12 6
Portugal
-0.7pts 18.4k 22.7 -0.4 Nov 2.7m -1.5% Nov
16 16
Belgium
+1.5pts (37.2k) 16.2 +1.1 Nov 2.4m -40.3% Oct
5 5
Austria
+2.7pts (56.3k) 45.8 +6.4 Nov 2.2m -22.2% Oct
11 11
PIPERACILLIN+ TAZOBACTAM
-2.2pts 415k 16.7 -11.7 Oct 154m 0.0% Oct
15 9
Germany
-8.0pts 6.0k 7.4 -4.6 Nov 69.8m +6.8% Nov
6 3
UK
-13.3pts 2.4m 17.4 -11.9 Oct 57.5m -4.6% Oct
1 1
Italy
-2.2pts 18.9k 0.7 -0.1 Nov 18.1m +10.2% Oct
10 5
Austria
-11.2pts 761 31.9 +10.7 Nov 5.6m -1.4% Oct
3 2
FLUTICASONE+ SALMETEROL
+7.1pts (8.8m) 26.0 -0.7 Oct 135m -21.8% Oct
13 11
UK
+4.7pts (3.3m) 35.4 +0.2 Oct 74.7m -21.6% Oct
3 3
Germany
+0.9pts (195k) 16.3 -0.7 Nov 26.8m -16.5% Nov
8 7
Italy
+0.1pts (31.4k) 3.0 +0.6 Nov 24.0m -20.3% Oct
2 2
Portugal
+0.7pts (28.8k) 24.0 -0.2 Nov 4.4m -16.2% Nov
3 3
Belgium
0.0pts 695 14.6 -0.7 Nov 4.4m -20.3% Oct
2 2
Austria
0.0pts (1.1k) 43.2 -2.7 Nov 2.9m -43.9% Oct
4 4
PANTOPRAZOLE
-6.8pts 5.9m 12.1 -1.1 Oct 131m -10.5% Oct
48 40
Germany
-1.1pts 499k 14.3 -0.6 Nov 60.8m -7.1% Nov
24 22
Italy
-0.3pts 79.3k 2.6 +0.7 Nov 50.9m -4.7% Oct
21 14
Belgium
+0.9pts (86.1k) 15.5 +2.7 Nov 12.0m +8.7% Oct
8 7
Austria
-1.2pts 43.6k 41.9 -0.3 Nov 5.4m -34.4% Oct
13 13
Portugal
-0.8pts 17.4k 22.5 +1.2 Nov 2.3m +4.7% Nov
20 17
UK
+2.2pts (12.7k) 33.0 -9.6 Oct 1.6m +8.4% Oct
3 2
ATORVASTATIN
-11.2pts 11.9m 7.7 -0.4 Oct 121m +5.6% Oct
39 35
UK
-25.6pts 15.9m 5.1 -1.6 Oct 63.5m +4.8% Oct
2 1
Italy
0.0pts 2.7k 2.9 +0.8 Nov 33.7m +5.3% Oct
19 12
Germany
-1.4pts 165k 14.0 -0.4 Nov 12.7m +23.2% Nov
14 14
Belgium
-1.3pts 63.3k 13.3 +0.2 Nov 5.0m -9.0% Oct
9 9
Portugal
-1.9pts 72.7k 21.5 +1.0 Nov 3.8m +17.6% Nov
17 17
Austria
+0.9pts (30.1k) 44.1 +0.9 Nov 3.1m +19.6% Oct
11 11
BUDESONIDE+ FORMOTEROL
+9.0pts (9.5m) 27.9 -1.9 Oct 109m -9.2% Oct
13 13
UK
+11.0pts (5.4m) 41.7 -1.7 Oct 50.2m -6.5% Oct
2 2
Germany
+1.4pts (543k) 16.7 -0.4 Nov 41.8m -0.2% Nov
10 10
Italy
-1.4pts 113k 1.5 +0.1 Nov 8.4m -8.1% Oct
3 3
Belgium
-1.5pts 65.9k 13.2 +0.8 Nov 4.2m -15.0% Oct
2 2
Portugal
-0.6pts 22.2k 22.8 -0.4 Nov 3.7m +11.8% Nov
4 4
Austria
+1.4pts (33.3k) 44.5 -0.5 Nov 2.4m -7.0% Oct
1 1
TIOTROPIUM BROMIDE
+7.7pts (7.2m) 26.6 -1.6 Oct 98.2m -13.4% Oct
8 7
UK
+5.5pts (2.7m) 36.2 -0.7 Oct 51.3m -13.5% Oct
1 1
Germany
-0.3pts 127k 15.1 +0.4 Nov 46.3m -6.3% Nov
8 7
MEROPENEM
+10.2pts (669k) 29.1 -16.2 Oct 88.9m -0.4% Oct
15 8
Germany
-2.7pts 6.0k 12.6 +1.8 Nov 47.1m +3.2% Nov
12 8
UK
-1.2pts 72.6k 29.6 -16.8 Oct 25.0m -2.3% Oct
3 1
Austria
+15.8pts (3.0k) 58.9 +22.0 Nov 3.9m +1.3% Oct
4 2
Belgium
-0.5pts 30 14.2 - Nov 378k -35.1% Oct
2 1
PACLITAXEL
+21.8pts (1.5m) 40.7 -21.8 Oct 87.6m +1.5% Oct
18 3
Germany
-8.1pts 85.6k 7.2 +3.3 Nov 35.5m +6.8% Nov
18 3
UK
+15.4pts (888k) 46.1 -18.5 Oct 29.9m +0.7% Oct
2 0
GLATIRAMER ACETATE
-0.6pts 341k 18.2 +1.5 Oct 83.8m +0.9% Oct
12 9
Germany
+1.1pts (550k) 16.5 +2.2 Nov 53.9m +7.4% Nov
10 9
Austria
-1.1pts 40.5k 42.1 -2.1 Nov 3.8m -9.8% Oct
5 5
Belgium
+4.3pts (99.0k) 18.9 +3.2 Nov 2.2m +9.4% Oct
1 1
FENTANYL
+1.2pts (757k) 20.0 -0.6 Oct 72.7m -8.2% Oct
38 34
Germany
-0.5pts 167k 14.9 +0.1 Nov 40.7m +0.2% Nov
24 24
UK
+7.5pts (1.1m) 38.2 +0.5 Oct 16.9m -9.2% Oct
10 8
Italy
-0.2pts 12.8k 2.7 +0.3 Nov 7.9m -5.5% Oct
11 8
Belgium
-0.6pts 20.3k 14.1 +1.2 Nov 3.8m -2.5% Oct
5 4
Austria
-0.8pts 14.9k 42.3 -0.4 Nov 2.1m -1.5% Oct
13 11
Portugal
+0.1pts (1.4k) 23.5 -1.4 Nov 1.3m +10.0% Nov
12 9
OMEPRAZOLE
-3.1pts 1.7m 15.8 -2.1 Oct 70.1m -10.5% Oct
49 45
Italy
-0.7pts 126k 2.2 +0.7 Nov 28.9m -6.0% Oct
25 18
UK
+1.7pts (246k) 32.5 -2.1 Oct 16.0m -17.7% Oct
3 3
Germany
-1.0pts 141k 14.4 -0.6 Nov 15.2m -16.0% Nov
18 16
Belgium
-0.9pts 52.3k 13.7 +0.3 Nov 6.3m -3.9% Oct
8 8
Portugal
-2.1pts 56.6k 21.3 +2.6 Nov 2.8m -4.5% Nov
22 21
Austria
-0.6pts 6.1k 42.5 -2.8 Nov 943k -16.1% Oct
9 9
LEVETIRACETAM
-0.7pts 351k 18.2 -0.6 Oct 68.7m +2.1% Oct
52 41
Germany
+0.1pts (23.5k) 15.5 +0.2 Nov 24.8m +11.4% Nov
29 24
UK
-3.4pts 655k 27.3 +0.2 Oct 21.1m +0.9% Oct
2 2
Italy
-1.0pts 107k 1.9 +0.3 Nov 16.2m +6.1% Oct
17 6
Belgium
+0.3pts (9.3k) 15.0 +1.0 Nov 3.2m -8.5% Oct
4 4
Austria
+1.5pts (23.4k) 44.7 +2.7 Nov 2.4m +2.5% Oct
15 14
Portugal
-0.3pts 4.1k 23.1 +1.6 Nov 1.5m +3.9% Nov
17 14
TACROLIMUS
-1.2pts 530k 17.7 +0.6 Oct 68.0m +5.0% Oct
19 16
Germany
-0.5pts 121k 14.9 +0.5 Nov 29.6m +4.6% Nov
17 15
UK
-11.9pts 2.0m 18.9 +1.1 Oct 29.5m +14.6% Oct
4 2
Italy
+1.0pts (4.1k) 3.9 -5.2 Nov 5.7m +6.7% Oct
5 4
Austria
+4.4pts (88.1k) 47.6 +1.6 Nov 2.1m +7.0% Oct
4 4
Belgium
+3.7pts (36.3k) 18.4 +6.2 Nov 1.0m -15.0% Oct
4 3
Portugal
-2.1pts 4.6k 21.2 -2.9 Nov 568k -5.9% Nov
2 1
PEMETREXED
+2.1pts (14.1k) 21.0 +17.1 Oct 65.1m -17.9% Oct
10 3
Germany
+6.9pts (36.9k) 22.3 +4.4 Nov 27.2m -15.1% Nov
9 2
PARACETAMOL
-1.9pts 582k 17.0 -1.3 Oct 61.7m -7.3% Oct
31 21
Italy
+1.2pts (129k) 4.1 +1.2 Nov 30.8m -1.8% Oct
14 5
UK
-6.0pts 999k 24.7 -0.1 Oct 22.1m -16.4% Oct
3 2
Portugal
-1.7pts 58.4k 21.6 +0.1 Nov 3.8m +13.5% Nov
18 14
Germany
+2.3pts (2.8k) 17.7 +0.2 Nov 2.4m -7.3% Nov
10 7
Belgium
+0.3pts (585) 14.9 -1.0 Nov 2.0m -15.4% Oct
5 1
Austria
-4.4pts 4.1k 38.8 -6.2 Nov 920k +6.4% Oct
6 6
AMOXICILLIN+ CLAVULANIC ACID
-3.3pts 1.4m 15.6 -0.9 Oct 61.2m +7.9% Oct
47 40
Italy
0.0pts (8.6k) 2.9 +1.0 Nov 30.3m +19.5% Oct
25 17
Germany
-0.1pts 4.6k 15.3 -0.4 Nov 11.2m +15.7% Nov
15 14
UK
+16.3pts (983k) 47.0 -0.2 Oct 10.5m -6.3% Oct
3 2
Belgium
+0.1pts (1.9k) 14.7 +2.4 Nov 3.8m -0.6% Oct
7 7
Portugal
-3.1pts 98.1k 20.3 +0.2 Nov 3.5m -2.5% Nov
17 14
Austria
-1.3pts 27.7k 41.8 +0.9 Nov 3.1m -1.3% Oct
6 6
MESALAZINE
+9.9pts (5.6m) 28.7 -3.2 Oct 60.4m +2.1% Oct
27 25
UK
+24.9pts (5.2m) 55.6 -4.2 Oct 21.6m +11.3% Oct
5 4
Germany
0.0pts (8.1k) 15.4 +0.1 Nov 20.2m +6.2% Nov
11 10
Italy
-0.1pts 19.3k 2.8 +0.1 Nov 13.9m +1.9% Oct
12 11
Portugal
+2.0pts (36.0k) 25.3 -2.4 Nov 1.8m +23.1% Nov
3 3
Belgium
+0.5pts (9.2k) 15.2 +1.4 Nov 1.6m -4.2% Oct
5 4
Austria
+6.1pts (102k) 49.2 -3.8 Nov 1.6m +1.9% Oct
3 3
PROPOFOL
+26.0pts (1.4m) 44.8 -2.1 Oct 57.9m -4.6% Oct
6 5
Germany
+0.5pts (13.1k) 15.8 -0.6 Nov 38.0m +4.6% Nov
5 5
UK
+41.7pts (1.1m) 72.4 +4.6 Oct 10.8m -8.4% Oct
2 1
Austria
+2.5pts (857) 45.6 -7.4 Nov 3.3m +3.2% Oct
3 3
Belgium
-4.1pts 1.3k 10.5 +13.2 Nov 122k -29.9% Oct
1 1
*Unprotected in at least one country
Growth figures throughout the page are calculated at constant exchange rate.
Powered by
